Priority Date: 07.06.16 (US 201662346755P)

NANOEMULSION COMPOSITIONS OF TAXOID DRUGS, AND METHODS FOR THE USE THEREOF TO TARGET CANCER CELLS AND CANCER STEM CELLS

  • Application ID: EP17810927
  • Status: Request for examination was made

Applicants

Research organisation logo small
Research Organisation
Research organisation logo small
Research Organisation

Attorney

Employment test 1 - 10 employees
Company dna latscha schollhorn partner ag
operating since 2012
Headquarter in Basel
active in Legal Services

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Latscha Schöllhorn Partner AG is specialized in A61. Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 07.06.2016 - Priority Date (US 201662346755P)
  • 14.12.2017 - Publication A1 (WO2017214260)
  • 10.04.2019 - Publication A1 (EP3463299)

IPC Classification